CC
GILD icon

Colrain Capital’s Gilead Sciences GILD Stock Holding History

Colrain Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-20,680
Closed -$1.29M – 49
2018
Q4 		$1.29M Hold
20,680
– – 1.68% 20
2018
Q3 		$1.6M Sell
20,680
-4,000
-16% -$302K 1.7% 22
2018
Q2 		$1.75M Sell
24,680
-4,870
-16% -$344K 2.06% 24
2018
Q1 		$2.23M Sell
29,550
-5,680
-16% -$452K 2.36% 22
2017
Q4 		$2.52M Sell
35,230
-47,108
-57% -$3.58M 2.09% 23
2017
Q3 		$6.67M Sell
82,338
-8,915
-10% -$682K 3.07% 12
2017
Q2 		$6.46M Buy
91,253
+9,180
+11% +$611K 2.62% 19
2017
Q1 		$5.57M Sell
82,073
-3,127
-4% -$220K 1.68% 22
2016
Q4 		$6.1M Buy
85,200
+50,362
+145% +$3.74M 1.28% 28
2016
Q3 		$2.76M Sell
34,838
-13,050
-27% -$1.06M 0.62% 37
2016
Q2 		$4M Sell
47,888
-41,612
-46% -$3.69M 0.8% 36
2016
Q1 		$8.22M Buy
89,500
+20,600
+30% +$1.86M 1.43% 27
2015
Q4 		$6.97M Buy
68,900
+7,550
+12% +$786K 0.71% 34
2015
Q3 		$6.02M Buy
61,350
+27,800
+83% +$3.09M 0.63% 40
2015
Q2 		$3.93M Buy
33,550
+17,550
+110% +$1.92M 0.35% 53
2015
Q1 		$1.57M Buy
+16,000
New +$1.62M 0.13% 66

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Colrain Capital's GILD Position: Q1 2019 in Review

Colrain Capital sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 20,680 shares — an estimated $1.29M sold.

Colrain Capital first reported a position in GILD in Q1 2015 and held it in 16 quarters. The position peaked at $8.22M in Q1 2016. 1,491 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

  • Colrain Capital reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
  • Colrain Capital sold 20,680 Gilead Sciences shares in Q1 2019, an estimated $1.29M.
  • Colrain Capital first reported a position in Gilead Sciences in Q1 2015 and held it in 16 quarters.
  • Colrain Capital's Gilead Sciences position peaked at $8.22M in Q1 2016.
  • 1,491 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Colrain Capital's 13F filing for Q1 2019, filed 2 May 2019.